Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975

Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions

Saudou, F., Finkbeiner, S. M., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,598

Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy

Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,559

Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease

Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417

Alzheimer’s β-peptide oligomer formation at physiologic concentrations

LeVine, H. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.08.014 · Cited by 125

Morin attenuates tau hyperphosphorylation by inhibiting GSK3β

Gong, E. J., Park, H. R., Kim, M. E., Piao, S., Lee, E., Jo, D., Chung, H. Y., Ha, N., Mattson, M. P., & Lee, J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.005 · Cited by 122

Membrane‐bound β‐amyloid oligomers are recruited into lipid rafts by a fyn‐dependent mechanism

Williamson, R., Usardi, A., Hanger, D. P., & Anderton, B. H. (2007) · The FASEB Journal · doi:10.1096/fj.07-9766com · Cited by 123

Alzheimer's Disease and the Amyloid β-Protein

Walsh, D. M., & Teplow, D. B. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00012-6 · Cited by 121

α-Mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation

Wang, Y., Xia, Z., Xu, J., Wang, Y., Hou, L., Qiu, Y. L., & Chen, H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.016 · Cited by 119

Rosemary species: a review of phytochemicals, bioactivities and industrial applications

Aziz, E., Batool, R., Akhtar, W., Shahzad, T., Malik, A. M., Shah, M. A., Iqbal, S., Rauf, A., Zengin, G., Bouyahya, A., et al. (2021) · South African Journal of Botany · doi:10.1016/j.sajb.2021.09.026 · Cited by 127

Phospholipases A2Mediate Amyloid-β Peptide-Induced Mitochondrial Dysfunction

Zhu, D., Lai, Y., Shelat, P. B., Hu, C., Sun, G. Y., & Lee, J. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3505-06.2006 · Cited by 119

Untitled work

(2012) · doi:10.1038/nrneurol.2012.118 · Cited by 122

Internalization of β-Amyloid Peptide by Primary Neurons in the Absence of Apolipoprotein E

Saavedra, L., Mohamed, A., Ma, V., Kar, S., & de Chaves, E. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701823200 · Cited by 118

On the role of sidechain size and charge in the aggregation of A β 42 with familial mutations

Yang, X., Meisl, G., Frohm, B., Thulin, E., Knowles, T. P. J., & Linse, S. S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803539115 · Cited by 117

Novel therapeutic strategies for the treatment of protein-misfolding diseases

Rochet, J. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000385 · Cited by 119

Pulsed hydrogen–deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation

Zhang, Y., Rempel, D. L., Zhang, J., Sharma, A. K., Mirica, L. M., & Gross, M. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309175110 · Cited by 118

Role of Cholesterol in APP Metabolism and Its Significance in Alzheimer’s Disease Pathogenesis

Maulik, M., Westaway, D. A., Jhamandas, J. H., & Kar, S. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8337-y · Cited by 121

Dimer Formation Enhances Structural Differences between Amyloid β-Protein (1–40) and (1–42): An Explicit-Solvent Molecular Dynamics Study

Barz, B., & Urbanc, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034345 · Cited by 118

The various aggregation states of β-amyloid 1–42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression

Tamagno, E., Bardini, P., Guglielmotto, M., Danni, O., & Tabaton, M. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.021 · Cited by 119

Formation of Toxic Aβ(1–40) Fibrils on GM1 Ganglioside-Containing Membranes Mimicking Lipid Rafts: Polymorphisms in Aβ(1–40) Fibrils

Okada, T., Ikeda, K., Wakabayashi, M., Ogawa, M., & Matsuzaki, K. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.072 · Cited by 116

Molecular Dynamics Simulations of Amyloid β -Peptide (1-42): Tetramer Formation and Membrane Interactions

Brown, A. M., & Bevan, D. R. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.08.001 · Cited by 117

Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study

Romano, G. L., Platania, C. B. M., Drago, F., Salomone, S., Ragusa, M., Barbagallo, C., Pietro, C. D., Purrello, M., Reibaldi, M., Avitabile, T., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00168 · Cited by 122

Aβ1–42 reduces P-glycoprotein in the blood–brain barrier through RAGE–NF-κB signaling

Park, R., Kook, S.-Y., Park, J.-C., & Mook‐Jung, I. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.258 · Cited by 116

The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine

Nyakas, C. J., Granic, I., Halmy, L. G., Banerjee, P., & Luiten, P. G. M. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.033 · Cited by 122

Cystatin C Protects Neuronal Cells from Amyloid-β-induced Toxicity

Tizón, B., Ribé, E. M., Mi, W., Troy, C. M., & Levy, E. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1291 · Cited by 115

Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivo

Klyubin, I. V., Walsh, D. M., Cullen, W. K., Fadeeva, J. V., Anwyl, R., Selkoe, D. J., & Rowan, M. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03389.x · Cited by 121

Formation of Toxic Fibrils of Alzheimer’s Amyloid β-Protein-(1–40) by Monosialoganglioside GM1, a Neuronal Membrane Component

Okada, T., Wakabayashi, M., Ikeda, K., & Matsuzaki, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.069 · Cited by 116

Clinical and Neuropathological Features of the Arctic APP Gene Mutation Causing Early-Onset Alzheimer Disease

Basun, H., Bogdanovic, N., Ingelsson, M., Almkvist, O., Näslund, J., Axelman, K., Bird, T. D., Nochlin, D., Schellenberg, G. D., Wahlund, L.-O., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.499 · Cited by 115

Conversion of non-fibrillar β-sheet oligomers into amyloid fibrils in Alzheimer’s disease amyloid peptide aggregation

Benseny‐Cases, N., Cócera, M., & Cladera, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.082 · Cited by 114

When astrocytes become harmful: Functional and inflammatory responses that contribute to Alzheimer's disease

Avila-Muñoz, E., & Arias, C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.004 · Cited by 114

Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo

Cordeiro, M. F., Guo, L., Coxon, K. M., Duggan, J., Nizari, S., Normando, E. M., Sensi, S. L., Sillito, A. M., Fitzke, F. W., Salt, T. E., et al. (2010) · Cell Death and Disease · doi:10.1038/cddis.2009.3 · Cited by 113

MAPK recruitment by β‐amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time

Bell, K. A., O’Riordan, K. J., Sweatt, J. D., & Dineley, K. T. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02722.x · Cited by 117

Methylation of the Imidazole Side Chains of the Alzheimer Disease Amyloid-β Peptide Results in Abolition of Superoxide Dismutase-like Structures and Inhibition of Neurotoxicity

Tickler, A. K., Smith, D. G., Ciccotosto, G. D., Tew, D. J., Curtain, C. C., Carrington, D., Masters, C. L., Bush, A. I., Cherny, R. A., Cappai, R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414178200 · Cited by 115

Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers

Rana, M., & Sharma, A. K. (2018) · Metallomics · doi:10.1039/c8mt00203g · Cited by 116

Unraveling the Early Events of Amyloid-β Protein (Aβ) Aggregation: Techniques for the Determination of Aβ Aggregate Size

Pryor, N. E., Moss, M. A., & Hestekin, C. N. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13033038 · Cited by 113

Prevention of β-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle events

Xu, X., Lei, Y., Luo, J., Wang, J., Zhang, S., Yang, X., Sun, M., Nuwaysir, E. F., Fan, G.-H., Zhao, J. Y., et al. (2012) · Stem Cell Research · doi:10.1016/j.scr.2012.11.005 · Cited by 115

Silibinin ameliorates anxiety/depression-like behaviors in amyloid β-treated rats by upregulating BDNF/TrkB pathway and attenuating autophagy in hippocampus

Song, X., Liu, B., Cui, L., Zhou, B., Liu, W., Xu, F., Hayashi, T., Hattori, S., Ushiki‐Kaku, Y., Tashiro, S., et al. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.07.023 · Cited by 112

Oligomer-specific Aβ toxicity in cell models is mediated by selective uptake

Chafekar, S. M., Baas, F., & Scheper, W. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.06.003 · Cited by 114

Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer’s disease

Drolle, E., Hane, F. T., Lee, B. Y., & Leonenko, Z. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.882354 · Cited by 120

ADDLs and the signaling web that leads to Alzheimer’s disease

Krafft, G. A., & Klein, W. L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.012 · Cited by 113

MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2

Liang, C., Zhu, H., Xu, Y., Huang, L. J., Ma, C., Deng, W., Liu, Y. M., & Qin, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.10.051 · Cited by 111

Aminopeptidase A contributes to the N‐terminal truncation of amyloid β‐peptide

Sévalle, J., Amoyel, A., Robert, P. H., Fournié‐Zaluski, M., Roques, B. P., & Checler, F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05950.x · Cited by 108

Human amyloid β‐induced neuroinflammation is an early event in neurodegeneration

Craft, J. M., Watterson, D. M., & Eldik, L. J. V. (2005) · Glia · doi:10.1002/glia.20306 · Cited by 111

Molecules that Target beta‐Amyloid

Stains, C. I., Mondal, K., & Ghosh, I. (2007) · ChemMedChem · doi:10.1002/cmdc.200700140 · Cited by 113

Aβ40 and Aβ42 Amyloid Fibrils Exhibit Distinct Molecular Recycling Properties

Sánchez, L., Madurga, S., Pukala, T. L., Vilaseca, M., López‐Iglesias, C., Robinson, C. V., Giralt, E., & Carulla, N. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1117123 · Cited by 108

β‐Amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH

Klug, G. M., Lošić, D., Supundi, Subasinghe, S., Aguilar, M., Martin, L. L., & Small, D. H. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03815.x · Cited by 109

Natural human antibodies to amyloid beta peptide

Szabo, P., Relkin, N. R., & Weksler, M. E. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.03.007 · Cited by 109

Preferential accumulation of Aβ(1−42) on gel phase domains of lipid bilayers: An AFM and fluorescence study

Choucair, A., Chakrapani, M., Chakravarthy, B., Katsaras, J., & Johnston, L. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.005 · Cited by 105

Structural diversity of dimers of the Alzheimer amyloid-β(25–35) peptide and polymorphism of the resulting fibrils

Wei, G., Jewett, A. I., & Shea, J. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/c000755m · Cited by 103

Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Aβ fibril formation pathway

Lee, S., Fernández, E., & Good, T. A. (2007) · Protein Science · doi:10.1110/ps.062514807 · Cited by 104

Human Serum Albumin Inhibits Aβ Fibrillization through a “Monomer-Competitor” Mechanism

Milojevic, J., Raditsis, A., & Melacini, G. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.08.028 · Cited by 104

Neuronal Pentraxin 1 Contributes to the Neuronal Damage Evoked by Amyloid-β and Is Overexpressed in Dystrophic Neurites in Alzheimer's Brain

Abad, M. A., Enguita, M., DeGregorio-Rocasolano, N., Ferrer, I., & Trullas, R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0575-06.2006 · Cited by 102

Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer’s disease mouse model

Washington, P. M., Morffy, N., Parsadanian, M., Zapple, D. N., & Burns, M. P. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3017 · Cited by 103

Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function

Li, S., Liu, B., Zhang, L., & Rong, L. (2014) · Bone · doi:10.1016/j.bone.2014.01.010 · Cited by 102

Impact of nanoplastics on Alzheimer ’s disease: Enhanced amyloid-β peptide aggregation and augmented neurotoxicity

Gou, X., Fu, Y., Li, J., Xiang, J., Yang, M., & Zhang, Y. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.133518 · Cited by 112

Amyloid β peptide adversely affects spine number and motility in hippocampal neurons

Shrestha, B. R., Vitolo, O. V., Joshi, P., Lordkipanidze, T. G., Shelanski, M. L., & Dunaevsky, A. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.07.011 · Cited by 106

Fingolimod Phosphate Attenuates Oligomeric Amyloid β–Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons

Doi, Y., Takeuchi, H., Horiuchi, H., Hanyu, T., Kawanokuchi, J., Jin, S., Parajuli, B., Sonobe, Y., Mizuno, T., & Suzumura, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061988 · Cited by 103

Amphiphilic Distyrylbenzene Derivatives as Potential Therapeutic and Imaging Agents for Soluble and Insoluble Amyloid β Aggregates in Alzheimer’s Disease

Sun, L., Cho, H.-J., Sen, S., Arango, A. S., Huynh, T. T., Huang, Y., Bandara, N., Rogers, B. E., Tajkhorshid, E., & Mirica, L. M. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c05470 · Cited by 101

An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity

Cisbani, G., & Cicchetti, F. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.121 · Cited by 107

Origin of metastable oligomers and their effects on amyloid fibril self-assembly

Hasecke, F., Miti, T., Perez, C., Barton, J., Schölzel, D., Gremer, L., Grüning, C. S. R., Matthews, G., Meisl, G., Knowles, T. P. J., et al. (2018) · Chemical Science · doi:10.1039/c8sc01479e · Cited by 103

Mangiferin and Morin Attenuate Oxidative Stress, Mitochondrial Dysfunction, and Neurocytotoxicity, Induced by Amyloid Beta Oligomers

Alberdi, E. M., Sánchez‐Gómez, M. V., Ruiz, A., Cavaliere, F., Ortiz-Sanz, C., Quintela‐López, T., Capetillo‐Zarate, E., Solé‐Domènech, S., & Matute, C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2856063 · Cited by 102

p75NTR Regulates Aβ Deposition by Increasing Aβ Production But Inhibiting Aβ Aggregation with Its Extracellular Domain

Wang, Y., Wang, X., Lu, J.-J., Li, Q., Gao, C., Liu, X.-H., Sun, Y., Yang, M., Lim, Y. P., Evin, G. M., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2733-10.2011 · Cited by 99

Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers

Wang, Q., Shah, N., Zhao, J. W., Wang, C., Zhao, C., Liu, L., Li, L., Zhou, F., & Zheng, J. (2011) · Physical Chemistry Chemical Physics · doi:10.1039/c1cp21156k · Cited by 100

Structural Study of Metastable Amyloidogenic Protein Oligomers by Photo‐Induced Cross‐Linking of Unmodified Proteins

Bitan, G. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)13012-8 · Cited by 97

Anti-Aβ single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease

Fukuchi, K.-I., Tahara, K., Kim, H., Maxwell, J. A., Lewis, T. L., Accavitti-Loper, M. A., Kim, H., Ponnazhagan, S., & Lalonde, R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.012 · Cited by 100

Behavior of neural stem cells in the Alzheimer brain

Waldau, B., & Shetty, A. K. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8053-y · Cited by 101

Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment

Fukumoto, K., Mizoguchi, H., Takeuchi, H., Horiuchi, H., Kawanokuchi, J., Jin, S., Mizuno, T., & Suzumura, A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.03.046 · Cited by 101

Glutamate and Amyloid β-Protein Rapidly Inhibit Fast Axonal Transport in Cultured Rat Hippocampal Neurons by Different Mechanisms

Hiruma, H., Katakura, T., Takahashi, S., Ichikawa, T., & Kawakami, T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08967.2003 · Cited by 114

Slingshot-Cofilin activation mediates mitochondrial and synaptic dysfunction via Aβ ligation to β1-integrin conformers

Woo, J. A., Zhao, X., Khan, H., Penn, C., Wang, X., Joly-Amado, A., Weeber, E., Morgan, D., & Kang, D. E. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.5 · Cited by 99

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

Magga, J. M., Puli, L., Pihlaja, R., Kanninen, K. M., Neulamaa, S., Malm, T., Härtig, W., Grosche, J., Goldsteins, G., Tanila, H., et al. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-90 · Cited by 100

Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin-phosphorylation

Davis, R. C., Marsden, I. T., Maloney, M. T., Minamide, L. S., Podlisny, M. B., Selkoe, D. J., & Bamburg, J. R. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-10 · Cited by 102

Mechanisms of amyloid plaque pathogenesis

Fiala, J. C. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0284-8 · Cited by 99

Bacterial Inclusion Bodies of Alzheimer's Disease β‐Amyloid Peptides Can Be Employed To Study Native‐Like Aggregation Intermediate States

Dasari, M., Espargaró, A., Sabaté, R., del Amo, J. M. L., Fink, U., Grelle, G., Bieschke, J., Ventura, S., & Reif, B. (2011) · ChemBioChem · doi:10.1002/cbic.201000602 · Cited by 96

P‐glycoprotein: a role in the export of amyloid‐β in Alzheimer's disease?

Chai, A. B., Leung, G. K. F., Callaghan, R., & Gelissen, I. C. (2019) · FEBS Journal · doi:10.1111/febs.15148 · Cited by 100

The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes

Mulder, S. D., Veerhuis, R., Blankenstein, M. A., & Nielsen, H. M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.001 · Cited by 97

A β 1-42 Induces Mild Endoplasmic Reticulum Stress in an Aggregation State–Dependent Manner

Chafekar, S. M., Hoozemans, J. J. M., Zwart, R., Baas, F., & Scheper, W. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1797 · Cited by 97

The binding of pullulan modified cholesteryl nanogels to Aβ oligomers and their suppression of cytotoxicity

Boridy, S., Takahashi, H., Akiyoshi, K., & Maysinger, D. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.010 · Cited by 97

High ability of apolipoprotein E4 to stabilize amyloid‐β peptide oligomers, the pathological entities responsible for Alzheimer's disease

Cerf, E., Gustot, A., Goormaghtigh, E., Ruysschaert, J.-M., & Raussens, V. (2011) · The FASEB Journal · doi:10.1096/fj.10-175976 · Cited by 92

Sequestration of Toxic Oligomers by HspB1 as a Cytoprotective Mechanism

Ojha, J., Masilamoni, G. J., Dunlap, D. D., Udoff, R. A., & Cashikar, A. G. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01187-10 · Cited by 99

Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid

Craft, J. M., Watterson, D. M., Hirsch, E., & Van Eldik, L. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-15 · Cited by 96

Amyloid-β Oligomers May Impair SNARE-Mediated Exocytosis by Direct Binding to Syntaxin 1a

Yang, Y., Kim, J., Kim, H. Y., Ryoo, N., Lee, S., Kim, Y., Rhim, H., & Shin, Y.-K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.044 · Cited by 88

Familial Alzheimer’s Disease Mutations Differentially Alter Amyloid β-Protein Oligomerization

Gessel, M. M., Bernstein, S. L., Kemper, M., Teplow, D. B., & Bowers, M. T. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300050d · Cited by 97

Bis(7)‐tacrine attenuates β amyloid‐induced neuronal apoptosis by regulating L‐type calcium channels

Fu, H., Li, W., Lao, Y., Luo, J., Lee, N. T. K., Kan, K. K. W., Tsang, H. W., Tsim, K. W. K., Pang, Y., Li, Z., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03960.x · Cited by 95

Aβ40 promotes neuronal cell fate in neural progenitor cells

Chen, Y., & Dong, C. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.94 · Cited by 94

Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity

Solesio, M. E., Peixoto, P. M., Debure, L., Madamba, S. M., de Leon, M. J., Wisniewski, T., Pavlov, E. V., & Fossati, S. (2018) · Aging Cell · doi:10.1111/acel.12787 · Cited by 92

Stable, Metastable, and Kinetically Trapped Amyloid Aggregate Phases

Miti, T., Mulaj, M., Schmit, J. D., & Muschol, M. (2014) · Biomacromolecules · doi:10.1021/bm501521r · Cited by 93

Stabilization of Neurotoxic Soluble β-Sheet-Rich Conformations of the Alzheimer's Disease Amyloid-β Peptide

Tew, D. J., Bottomley, S. P., Smith, D. P., Ciccotosto, G. D., Babon, J., Hinds, M. G., Masters, C. L., Cappai, R., & Barnham, K. J. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.119909 · Cited by 93

A Ganglioside-induced Toxic Soluble Aβ Assembly

Yamamoto, N., Matsubara, E., Maeda, S., Minagawa, H., Takashima, A., Maruyama, W., Michikawa, M., & Yanagisawa, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606202200 · Cited by 96

The S100B/RAGE Axis in Alzheimer's Disease

Leclerc, E., Sturchler, E., & Vetter, S. W. (2010) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2010/539581 · Cited by 97

Interaction between NH2-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration

Amadoro, G., Corsetti, V., Atlante, A., Florenzano, F., Capsoni, S., Bussani, R., Mercanti, D., & Calissano, P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.001 · Cited by 95

Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease

Zhang, W., Hao, J., Liu, R., Zhang, Z., Lei, G., Su, C., Miao, J., & Li, Z. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.072 · Cited by 100

Prolonged Exposure of Cortical Neurons to Oligomeric Amyloid-β Impairs NMDA Receptor Function Via NADPH Oxidase-Mediated ROS Production: Protective Effect of Green Tea (-)-Epigallocatechin-3-Gallate

He, Y., Cui, J., Lee, J. C., Ding, S., Chalimoniuk, M., Simonyi, Á., Sun, A. Y., Gu, Z., Weisman, G. A., Wood, W. G., et al. (2011) · ASN NEURO · doi:10.1042/an20100025 · Cited by 95

TDP-43 interacts with amyloid-β, inhibits fibrillization, and worsens pathology in a model of Alzheimer’s disease

Shih, Y., Tu, L., Chang, T.-Y., Ganesan, K., Chang, W.-W., Chang, P.-S., Fang, Y.-S., Lin, Y.-T., Jin, L., & Chen, Y. (2020) · Nature Communications · doi:10.1038/s41467-020-19786-7 · Cited by 92

Aminopyridazines inhibit β-amyloid-induced glial activation and neuronal damage in vivo

Craft, J. M., Watterson, D. M., Frautschy, S. A., & Eldik, L. J. V. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.01.006 · Cited by 94

Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease

Lee, L., Dale, E., Staniszewski, A., Zhang, H., Saeed, F., Sakurai, M., Fà, M., Orozco, I. J., Michelassi, F. E., Akpan, N., et al. (2014) · Scientific Reports · doi:10.1038/srep07190 · Cited by 91

Multifaceted roles of pericytes in central nervous system homeostasis and disease

Zheng, Z., Chopp, M., & Chen, J. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20911331 · Cited by 93

The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Aβ peptides

Liao, M. Q., Tzeng, Y., Chang, L. Y. X., Huang, H., Lin, T.-C., Chyan, C. L., & Chen, Y. C. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.026 · Cited by 90

The ‘O-acyl isopeptide method’ for the synthesis of difficult sequence-containing peptides: application to the synthesis of Alzheimer's disease-related amyloid β peptide (Aβ) 1-42

Sohma, Y., Hayashi, Y., Kimura, M., Chiyomori, Y., Taniguchi, A., Sasaki, M., Kimura, T., & Kiso, Y. (2005) · Journal of Peptide Science · doi:10.1002/psc.649 · Cited by 90

Low‐n oligomers as therapeutic targets of Alzheimer’s disease

Ono, K., & Yamada, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07187.x · Cited by 76

Amyloid-β-induced Synapse Damage Is Mediated via Cross-linkage of Cellular Prion Proteins

Bate, C., & Williams, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248724 · Cited by 93

N-truncated amyloid-β oligomers induce learning impairment and neuronal apoptosis

Youssef, I., Florent‐Béchard, S., Malaplate, C., Koziel, V., Bihain, B. E., Olivier, J. L., Leininger‐Muller, B., Kriem, B., Oster, T., & Pillot, T. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.005 · Cited by 97

Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies

Bram, Y., Frydman‐Marom, A., Yanai, I., Gilead, S., Shaltiel‐Karyo, R., Amdursky, N., & Gazit, E. (2014) · Scientific Reports · doi:10.1038/srep04267 · Cited by 89

The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology♦

Podoly, E., Shalev, D. E., Shenhar‐Tsarfaty, S., Bennett, E. R., Assayag, E. B., Wilgus, H., Livnah, O., & Soreq, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.004952 · Cited by 89

Small Molecule Microarrays Enable the Discovery of Compounds That Bind the Alzheimer’s Aβ Peptide and Reduce its Cytotoxicity

Chen, J., Armstrong, A. H., Koehler, A. N., & Hecht, M. H. (2010) · Journal of the American Chemical Society · doi:10.1021/ja107552s · Cited by 89

In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis

Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015

P1‐167: Effects of beta‐amyloid oligomers on neuronal viability and microglial activation

Ferrera, D., Canale, C., Benfenati, F., & Gasparini, L. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.04.173

Effect of different Aβ1-42 assemblies on neuronal cell viability

Morkūnienė, R., Čižas, P., Budvytytė, R., Valinčius, G., & Borutaitė, V. (2010) · Lithuanian University of Health Sciences

P4–014: Divergent cytotoxic mechanisms of soluble and fibrillar forms of AAY in human cortical neurons

Deshpande, A. M., Mina, E. W., Glabe, C. G., & Busciglio, J. A. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1752

Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of β-amyloid peptide

Ward, R. V., JENNINGS, K. H., Jepras, R., Neville, W. A., OWEN, D. E., HAWKINS, J., Christie, G., Davis, J. B., George, A. R., Karran, E. H., et al. (2000) · Biochemical Journal · doi:10.1042/bj3480137 · Cited by 153